Sarepta Therapeutics, Inc. (NASDAQ:SRPT) will be hosting a conference call at 4:30 PM eastern time on 5th November 2020, to discuss its 3Q20 financial results with the investment community.
A live webcast with presentations will be available on the Internet by visiting the Company website www.sarepta.com
Earnings Expectation
Sarepta Therapeutics, Inc. is reporting third quarter financial results on Thursday 5th November 2020, after market close.
According to analysts surveyed by Thomson Reuters, SRPT is expected to report 3Q20 loss of $ 1.71 per share from revenue of $ 137.43 million.
For the full year, analysts anticipate top line of $ 570.39 million, while looking forward to loss of $ 5.98 per share bottom line.
Sarepta Therapeutics, Inc. focuses on the discovery and development of RNA-based therapeutics, gene therapy, and other genetic medicine approaches for the treatment of rare diseases. The company offers EXONDYS 51, a disease-modifying therapy for duchenne muscular dystrophy (DMD).
